1. Home
  2. WLYB vs LMAT Comparison

WLYB vs LMAT Comparison

Compare WLYB & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Wiley & Sons Inc.

WLYB

John Wiley & Sons Inc.

N/A

Current Price

$54.28

Market Cap

2.6B

ML Signal

N/A

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$79.00

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLYB
LMAT
Founded
1807
1983
Country
United States
United States
Employees
4500
N/A
Industry
Books
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.1B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
WLYB
LMAT
Price
$54.28
$79.00
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$105.80
AVG Volume (30 Days)
208.0
258.6K
Earning Date
06-16-2026
05-05-2026
Dividend Yield
3.45%
0.93%
EPS Growth
N/A
30.57
EPS
N/A
1.42
Revenue
N/A
$249,602,000.00
Revenue This Year
$1.04
$14.21
Revenue Next Year
$2.36
$8.88
P/E Ratio
$15.27
$155.56
Revenue Growth
N/A
13.53
52 Week Low
$29.16
$79.40
52 Week High
$54.73
$118.01

Technical Indicators

Market Signals
Indicator
WLYB
LMAT
Relative Strength Index (RSI) 68.93 30.51
Support Level $36.32 N/A
Resistance Level N/A $89.00
Average True Range (ATR) 0.23 4.09
MACD 0.03 -1.04
Stochastic Oscillator 78.75 9.20

Price Performance

Historical Comparison
WLYB
LMAT

About WLYB John Wiley & Sons Inc.

John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning, which includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: